ArcticZymes Technologies ASA (FRA:B4V) Net Interest Margin (Bank Only) %


FRA:B4V ArcticZymes Technologies ASA FRA:B4V
78 GF Score
Price €1.66
GF Value €2.14
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:B4V
78GF Score
ArcticZymes Technologies ASA FRA:B4V
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ArcticZymes Technologies ASA (FRA:B4V) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of €1.66 is trading 22.4% below its estimated GF Value™ of €2.14.

Key valuation signals for FRA:B4V:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €2.14 vs. price of €1.66 (22.4% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the FRA:B4V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ArcticZymes Technologies ASA Business Description

Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
78GF Score

Get the complete analysis for FRA:B4V

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.66
Price
€2.14
GF Value